Company page

Aptahem Ab

Aptahem Ab is a public company listed on the Swedish market under the ticker APTA. The company has a market capitalization of approximately 2.72 million USD. Aptahem focuses on developing innovative therapies, particularly in the field of immunology.

profileAPTA:NGMAI content: aiUpdated June 24, 2026/company/aptahem-ab/c-enpm8vb2
Aptahem Ab logo
Ticker
APTA:NGM
Asset type
Stock
Market cap
$2.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NGM
Currency
SEK